Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4715-4720

  Galande, Amit K ^a   Hilderbrand, Scott A ^a   Weissleder, Ralph ^a   Tung, Ching Hsuan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; DENDRIMER; DIPEPTIDE; ETHYLENE OXIDE; FLUORESCENT DYE; LEUCYLARGININE; MACROGOL; MULTIPLE ANTIGENIC PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG; VACCINE;

AMINO TERMINAL SEQUENCE; ARTICLE; DRUG DELIVERY SYSTEM; FLUORESCENCE; GENE DELIVERY SYSTEM; MOLECULAR MIMICRY; MOLECULAR PROBE; PROTEIN DEGRADATION; SOLID PHASE SYNTHESIS; SOLUBILITY;

CATHEPSINS; DENDRIMERS; DIPEPTIDES; FLUORESCENT DYES; HYDROLYSIS; POLYETHYLENE GLYCOLS; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746776797     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm051001a     Document Type: Article

References (23)

1. Tung, C. H. Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 2004, 76, 391-403.
2. Pham, W.; Choi, Y. D.; Weissleder, R.; Tung, C. H. Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconjugate Chem. 2004, 15, 1403-1407.
3. Weissleder, R.; Tung, C. H.; Mahmood, U.; Bogdanov, A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnol. 1999, 17, 375-378.
4. Josephson, L.; Kircher, M. F.; Mahmood, U.; Tang, Y.; Weissleder, R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjugate Chem. 2002, 13, 554-560.
5. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41, 189-207.
6. Merrifield, R. B. Solid-phase peptide synthesis. 1. Synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154.
7. Tam, J. P. Synthetic peptide vaccine design - synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5409-5413.
8. Crespo, L.; Sanclimens, G.; Pons, M.; Giralt, E.; Royo, M.; Albericio, F. Peptide and amide bond-containing dendrimers. Chem. Rev. 2005, 105, 1663-1681.
9. Bromme, D.; Okamoto, K.; Wang, B. B.; Biroc, S. Human cathepsin O-2, a matrix protein-degrading cysteine protease expressed in osteoclasts - functional expression of human cathepsin O-2 in spodoptera frugiperda and characterization of the enzyme. J. Biol. Chem. 1996, 271, 2126-2132.
10. Bossard, M. J.; Tomaszek, T. A.; Thompson, S. K.; Amegadzie, B. Y.; Hanning, C. R.; Jones, C.; Kurdyla, J. T.; McNulty, D. E.; Drake, F. H.; Gowen, M.; Levy, M. A. Proteolytic activity of human osteoclast cathepsin K - expression, purification, activation, and substrate identification. J. Biol. Chem. 1996, 271, 12517-12524.
11. Hilderbrand, S. A.; Kelly, K. A.; Weissleder, R.; Tung, C. H. Monofunctional near-infrared fluorochromes for imaging applications. Bioconjugate Chem. 2005, 16, 1275-1281
12. Caliceti, P.; Veronese, F. M. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv. Drug Deliv. Rev. 2003, 55, 1261-1277.
13. Packard, B. Z.; Toptygin, D. D.; Komoriya, A.; Brand L. Design of profluorescent protease substrates guided by exciton theory. Methods Enzymol. 1997, 278, 15-23.
14. Johansson, M. K.; Cook, R. M. Intramolecular dimers: A new design strategy for fluorescence-quenched probes. Chem. Eur. J. 2003, 9, 3466-3471.
15. Weissleder, R.; Ntziachristos, V. shedding light onto live molecular targets. Nat. Med. 2003, 9, 123-128.
16. Lee, S. H.; Lee S.; Youn, Y. S.; Na, D. H.; Chae, S. Y.; Byun, Y.; Lee, K. C. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. Bioconjugate Chem. 2005, 16, 377-382.
17. Chen, X. Y.; Park, R.; Hou, Y. P.; Khankaldyyan, V.; Gonzales-Gomez, I.; Bading, J. R.; Laug, W. E.; Conti, P. S. MicroPET imaging of brain tumor angiogenesis with F-18-labeled PEGylated RGD peptide. Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 1081-1089.
18. Turk, V.; Kos, J.; Turk, B. Cysteine cathepsins (proteases) - on the main stage of cancer? Cancer Cell 2004, 5, 409-410.
19. Kos, J.; Sekirnik, A.; Kopitar, G.; Cimerman, N.; Kayser, K.; Stremmer, A.; Fiehn, W.; Werle, B. Cathepsin S in tumors, regional lymp nodes, and sera of patients with lung cancer: Relation to prognosis. Br. J. Cancer 2001, 85, 1193-1200.
20. Flannery, T.; Gibson, D.; Mirakhur, M.; McQuaid, S.; Greenan, C.; Trimble, A.; Walker B.; McCormick, D.; Johnston, P. G. The clinical significance of cathepsin S expression in human astrocytomas. Am. J. Pathol. 2003, 163, 175-182.
21. Yasuda, Y.; Kaleta, J.; Bromme, D. The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics. Adv. Drug Deliv. Rev. 2005, 57, 973-993.
22. Liu, J.; Sukhova, G. K.; Sun, J. S.; Xu, W. H.; Libby, P.; Shi, G. P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1359-1366.
23. Kay, C.; Lorthioir, O. E.; Parr, N. J.; Congreve, M.; McKeown, S. C.; Scicinski, J. J.; Ley, S. V. Solid-phase reaction monitoring - chemical derivatization and off-bead analysis. Biotechnol. Bioeng. 2000, 71, 110-118.